Inventiva (IVA) Current Deferred Tax Assets (2023 - 2024)
Inventiva (IVA) recorded quarterly Current Deferred Tax Assets of $2137.2 in Q4 2024, down 0.77% quarter-over-quarter from $2153.8 in Q2 2024, and down 95.16% on a YoY basis from $44113.5 in Q1 2024.
Inventiva (IVA) Current Deferred Tax Assets (2023 - 2024) Analysis & Trends
Inventiva's Current Deferred Tax Assets history runs 2 years deep, the most recent figure standing at $2137.2 for Q4 2024.
- In Q4 2024, Current Deferred Tax Assets fell 95.16% year-over-year to $2137.2; the TTM figure through Dec 2024 stood at $2137.2 (down 95.16% YoY), while the FY2024 annual figure was $2137.2, down 95.16% from the prior year.
- Current Deferred Tax Assets was $2137.2 for Q4 2024 at Inventiva, down from $2153.8 in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $44113.5 in Q4 2023 to a low of $2137.2 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2,137.19 |
| Dec 31, 2024 | 2,137.19 |
| Jun 30, 2024 | 2,153.78 |
| Jun 30, 2024 | 2,153.78 |
| Dec 31, 2023 | 44,113.54 |
| Dec 31, 2023 | 44,113.54 |